Skip to main content
Nancy Kemeny, MD, Oncology, New York, NY, Memorial Sloan Kettering Cancer Center

NancyEKemenyMD

Oncology New York, NY

Attending Physician, Memorial Sloan-Kettering Cancer Center

Overview of Dr. Kemeny

Dr. Nancy Kemeny is an oncologist in New York, NY and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center and Memorial Hospital for Cancer and allied Diseases. She received her medical degree from Rutgers New Jersey Medical School and has been in practice 46 years. Dr. Kemeny accepts several types of health insurance, listed below. She is one of 463 doctors at Memorial Sloan Kettering Cancer Center and one of 88 doctors at Memorial Hospital for Cancer and allied Diseases who specialize in Oncology. She has more than 100 publications and over 500 citings.

Education & Training

  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1974 - 1976
  • New York Medical College at St Vincent's Hospital and Medical Center of New York
    New York Medical College at St Vincent's Hospital and Medical Center of New YorkResidency, Internal Medicine, 1971 - 1974
  • Rutgers New Jersey Medical School
    Rutgers New Jersey Medical SchoolClass of 1971

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2021 - Present
  • NY State Medical License
    NY State Medical License 1972 - 2025
  • NJ State Medical License
    NJ State Medical License Active through 2025
  • VT State Medical License
    VT State Medical License 2022 - 2024
  • NC State Medical License
    NC State Medical License 2020 - 2022
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • New York Magazine: Top Doctors Castle Connolly, 2002-2014
  • America's Top Doctors Castle Connolly, 2002-2014
  • Top Doctors: New York Metro Area Castle Connolly, 2002-2014
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Quantitative Imaging Features of Pretreatment CT Predict Volumetric Response to Chemotherapy in Patients with Colorectal Liver Metastases  
    Andrea Cercek, William R Jarnagin, Jinru Shia, Peter J Allen, Kenneth P Seastedt, Nancy E Kemeny, Ronald P DeMatteo, Vinod P Balachandran, T Peter Kingham, European Radiology

Lectures

  • Randomized phase II trial of adjuvant hepatic arterial infusion (HAI) + systemic FOLFIRI +/- panitumumab (Pmab) in patients with resected RAS wild type colorectal canc... 
    2019 ASCO Annual Meeting - 6/1/2019

Press Mentions

  • Doctors Fret as Firm Stops Making Cancer Drug Pump
    Doctors Fret as Firm Stops Making Cancer Drug PumpApril 26th, 2018
  • Liver-Directed Therapy Shows Improvement in mCRC
    Liver-Directed Therapy Shows Improvement in mCRCJanuary 5th, 2018

Grant Support

  • Therapy Of Hepatic Metastases From Colorectal CarcinomaNational Cancer Institute1993–2001
  • ST Vincent'S Community Clinical Oncology ProgramNational Cancer Institute1987–1989

Professional Memberships

Hospital Affiliations

Insurance Accepted

  • Aetna Choice POS II
    Aetna HMO
    BCBS Blue Card PPO
    CIGNA HMO
    CIGNA Open Access
    CIGNA PPO
    Empire BCBS HMO
    Empire BCBS PPO
    Great West PPO
    Humana ChoiceCare Network PPO
    Multiplan PHCS PPO
    Multiplan PPO
    MVP Healthcare PPO
    Oxford Health Freedom
    Oxford Health Liberty
    QualCare HMO
    QualCare PPO
    United Healthcare - Direct Choice Plus POS
    United Healthcare - Direct Options PPO
  • Please verify your coverage with the provider's office directly when scheduling an appointment